10 Followers on Owler

Galera Therapeutics

develops and commercializes novel mechanism-based therapies for the treatment of cancer... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Galera Therapeutics

develops and commercializes novel mechanism-based therapies for the treatment of cancer... Read more
Galera Therapeutics President & CEO: Mel Sorensen

President & CEO

Mel Sorensen

CEO Approval Rating

81/100

2009

PublicIndependent CompanyNASDAQGRTX

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Annual Revenue
<$1M
Employees
30
Funding
$237.1M
Acquisitions
1

News

Acquisition
Jan 01, 2025
GlobeNewswire
Galera Therapeutics acquired Nova Pharmaceuticals, Inc. for undisclosed amount
Funding
Dec 29, 2024
SEC
Galera Therapeutics received $2.7M in Post-IPO Equity Funding

Galera Therapeutics Competitors

1OncoFusion Therapeutics
2Euclises
3Aradigm
Unlock more competitors

Trending Companies